These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24050239)

  • 1. Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity.
    Lublin AL; Link CD
    Drug Discov Today Technol; 2013; 10(1):e115-e119. PubMed ID: 24050239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human amyloid β peptide and tau co-expression impairs behavior and causes specific gene expression changes in Caenorhabditis elegans.
    Wang C; Saar V; Leung KL; Chen L; Wong G
    Neurobiol Dis; 2018 Jan; 109(Pt A):88-101. PubMed ID: 28982592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ameliorative effect of Luffa cylindrica fruits on Caenorhabditis elegans and cellular models of Alzheimer's disease-related pathology via autophagy induction.
    Long T; Chen X; Qin DL; Zhu YF; Zhou YJ; He YN; Fu HJ; Tang Y; Yu L; Huang FH; Wang L; Yu CL; Law BY; Wu JM; Wu AG; Zhou XG
    Phytother Res; 2023 Oct; 37(10):4639-4654. PubMed ID: 37394882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.
    Griffin EF; Caldwell KA; Caldwell GA
    ACS Chem Neurosci; 2017 Dec; 8(12):2596-2606. PubMed ID: 29022701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of an improved model of amyloid-beta (Aβ₁₋₄₂) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease.
    McColl G; Roberts BR; Pukala TL; Kenche VB; Roberts CM; Link CD; Ryan TM; Masters CL; Barnham KJ; Bush AI; Cherny RA
    Mol Neurodegener; 2012 Nov; 7():57. PubMed ID: 23171715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the molecular basis of Alzheimer's disease using a Caenorhabditis elegans model system.
    Ewald CY; Li C
    Brain Struct Funct; 2010 Mar; 214(2-3):263-83. PubMed ID: 20012092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and functional characterization of a putative IDE, C28F5.4 (ceIDE-1), in Caenorhabditis elegans: Implications for Alzheimer's disease.
    Haque R; Nazir A
    Biochim Biophys Acta; 2016 Nov; 1860(11 Pt A):2454-2462. PubMed ID: 27443962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of policosanol from insect wax on amyloid β-peptide-induced toxicity in a transgenic Caenorhabditis elegans model of Alzheimer's disease.
    Zhang X; Ma C; Sun L; He Z; Feng Y; Li X; Gan J; Chen X
    BMC Complement Med Ther; 2021 Mar; 21(1):103. PubMed ID: 33785017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeutics.
    Paul D; Chipurupalli S; Justin A; Raja K; Mohankumar SK
    J Pharmacol Toxicol Methods; 2020; 106():106932. PubMed ID: 33091537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caenorhabditis elegans hub genes that respond to amyloid beta are homologs of genes involved in human Alzheimer's disease.
    Godini R; Pocock R; Fallahi H
    PLoS One; 2019; 14(7):e0219486. PubMed ID: 31291334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Bioactive Products and Alzheimer's Disease Pathology: Lessons from
    Navarro-Hortal MD; Romero-Márquez JM; Osta S; Jiménez-Trigo V; Muñoz-Ollero P; Varela-López A
    Diseases; 2022 May; 10(2):. PubMed ID: 35645249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monascin from Monascus-Fermented Products Reduces Oxidative Stress and Amyloid-β Toxicity via DAF-16/FOXO in Caenorhabditis elegans.
    Shi YC; Pan TM; Liao VH
    J Agric Food Chem; 2016 Sep; 64(38):7114-20. PubMed ID: 27554775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus Subtilis Delays Neurodegeneration and Behavioral Impairment in the Alzheimer's Disease Model Caenorhabditis Elegans.
    Cogliati S; Clementi V; Francisco M; Crespo C; Argañaraz F; Grau R
    J Alzheimers Dis; 2020; 73(3):1035-1052. PubMed ID: 31884470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
    Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
    Elife; 2020 Mar; 9():. PubMed ID: 32228858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. rBTI reduced β-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
    Li J; Cui X; Ma X; Wang Z
    Exp Gerontol; 2017 Mar; 89():78-86. PubMed ID: 28119052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diphenyl-diselenide suppresses amyloid-β peptide in Caenorhabditis elegans model of Alzheimer's disease.
    Zamberlan DC; Arantes LP; Machado ML; Golombieski R; Soares FA
    Neuroscience; 2014 Oct; 278():40-50. PubMed ID: 25130558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucoidan inhibits amyloid-β-induced toxicity in transgenic Caenorhabditis elegans by reducing the accumulation of amyloid-β and decreasing the production of reactive oxygen species.
    Wang X; Yi K; Zhao Y
    Food Funct; 2018 Jan; 9(1):552-560. PubMed ID: 29260173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rose Essential Oil Delayed Alzheimer's Disease-Like Symptoms by SKN-1 Pathway in C. elegans.
    Zhu S; Li H; Dong J; Yang W; Liu T; Wang Y; Wang X; Wang M; Zhi D
    J Agric Food Chem; 2017 Oct; 65(40):8855-8865. PubMed ID: 28915354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
    Calahorro F; Ruiz-Rubio M
    Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cranberry Extract Standardized for Proanthocyanidins Alleviates β-Amyloid Peptide Toxicity by Improving Proteostasis Through HSF-1 in Caenorhabditis elegans Model of Alzheimer's Disease.
    Guo H; Cao M; Zou S; Ye B; Dong Y
    J Gerontol A Biol Sci Med Sci; 2016 Dec; 71(12):1564-1573. PubMed ID: 26405062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.